Skip to main content
Caplight Logo









Oorja Bio, Inc.

Oorja Bio, Inc.

Private
Houston, TexasHealthcare & Life Scienceshttps://oorjabio.com/

Last Round

Series A

May 19, 2026

Total Funding Raised

$30M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Oorja Bio is a clinical-stage biotechnology company developing therapies for idiopathic pulmonary fibrosis (IPF) and other fibrotic and cardiopulmonary diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

idiopathic pulmonary fibrosisIPFpeptide therapeuticclinical stage biotechfibrotic disease therapydisease-modifying therapyanti-fibrotic therapyasset-centric biotechdrug in-licensingcardiopulmonary diseasecellular repair therapyPhase 2 clinical trial

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Oorja Bio, Inc. Comparables

Compare Oorja Bio, Inc. with similar companies based on industry and business-model similarity.

Oorja Bio, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Rein Therapeutics
85%
Celea Therapeutics
83%
Pulmongene
79%

Oorja Bio, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 19, 2026

Oorja Bio, Inc. Investors

Notable investors and investment history

Oorja Bio, Inc. investors
InvestorRounds
Westlake Village BioPartnersSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 19, 2026

    $30M round led by Westlake Village Biopartners

Oorja Bio, Inc. Filings

Explore SEC and related filing metadata, where available.

Oorja Bio, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Oorja Bio, Inc.'s valuation, stock price, and market status.

Is Oorja Bio, Inc. a public or private company?

Oorja Bio, Inc. is a private company.

What is the current stock price of Oorja Bio, Inc.?

Oorja Bio, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Oorja Bio, Inc. worth (valuation)?

Valuation information for Oorja Bio, Inc. is not publicly available.

Can I buy Oorja Bio, Inc. stock?

Oorja Bio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Oorja Bio, Inc.'s last funding round?

Oorja Bio, Inc.'s most recent funding round was Series A on May 19, 2026.

Who are the main investors in Oorja Bio, Inc.?

Key investors in Oorja Bio, Inc. include Westlake Village Biopartners.

Will Oorja Bio, Inc. IPO soon?

No public IPO plans have been announced for Oorja Bio, Inc..

How can I track Oorja Bio, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Oorja Bio, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHouston, Texas
Year Founded2026
Last FundingMay 19, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?